Medtronic Stock Near Crucial Support – Buy Signal?
Medtronic (MDT) stock should be on your watchlist. Here is why – it is currently trading in the support zone ($76.66 – $84.72), levels from which it has bounced meaningfully before. Since it first started trading, Medtronic stock received buying interest at this level 8 times and subsequently went on to generate 20.1% in average peak returns.
| Peak Return | Days to Peak Return | |
|---|---|---|
| 6/6/2019 | 27.6% | 245 |
| 4/6/2020 | 9.8% | 11 |
| 6/12/2020 | 21.5% | 132 |
| 10/30/2020 | 36.4% | 313 |
| 5/9/2024 | 3.8% | 8 |
| 8/8/2024 | 13.1% | 76 |
| 12/13/2024 | 15.6% | 84 |
| 5/23/2025 | 32.7% | 186 |
Yet, a support zone alone isn’t enough; rebounds are more likely when fundamentals, sentiment, and market conditions line up. How does that look for MDT?
Rebound Likely: Strong Q4, upbeat FY27 outlook, analyst conviction
Medtronic’s Q4 FY26 showcased decade-high revenue growth and an EPS beat, driven by strong Cardiovascular and Cardiac Ablation Solutions performance. FY27 guidance forecasts continued organic growth, bolstered by strategic investments in robotic surgery and advanced ablation. Analyst consensus is largely bullish, anticipating significant upside. Despite minor financial stress indicators, a robust product pipeline and favorable industry shifts in AI and care delivery support a likely rebound.
- BSX, MDT Top Abbott Laboratories Stock on Price & Potential
- RMD Looks Smarter Buy Than Medtronic Stock
- Pay Less, Gain More: RMD, MDT Top Abbott Laboratories Stock
- Medtronic Stock Hands $28 Bil Back – Worth a Look?
- RMD, MDT Top Revvity Stock on Price & Potential
- Large Cap Stocks Trading At 52-Week High
How Do MDT Financials Look Right Now?
- Revenue Growth: 6.9% LTM and 4.9% last 3-year average.
- Cash Generation: Nearly 15.2% free cash flow margin and 18.6% operating margin LTM.
- Recent Revenue Shocks: The minimum annual revenue growth in the last 3 years for MDT was 2.7%.
- Valuation: MDT stock trades at a PE multiple of 22.4
| MDT | S&P Median | |
|---|---|---|
| Sector | Health Care | – |
| Industry | Health Care Equipment | – |
| PE Ratio | 22.4 | 23.6 |
|
|
||
| LTM* Revenue Growth | 6.9% | 7.4% |
| 3Y Average Annual Revenue Growth | 4.9% | 5.7% |
| Min Annual Revenue Growth Last 3Y | 2.7% | 0.6% |
|
|
||
| LTM* Operating Margin | 18.6% | 18.4% |
| 3Y Average Operating Margin | 18.5% | 18.3% |
| LTM* Free Cash Flow Margin | 15.2% | 14.5% |
*LTM: Last Twelve Months | For more details on MDT fundamentals, read Buy or Sell MDT Stock.
And What If The Support Breaks?
MDT isn’t immune to big drops either. It fell about 36% in the Dot-Com bubble and nearly 57% in the Global Financial Crisis. The 2018 correction was milder, around 17%, but still noticeable. Covid hit it for almost 40%, and the inflation shock knocked it down 45%. Even strong stocks take a hit when things go south. Good fundamentals matter, but they won’t stop sharp sell-offs when panic sets in.
But the risk is not limited to major market crashes. Stocks fall even when markets are in good shape – think events like earnings, business updates, outlook changes. Read MDT Dip Buyer Analyses to see how the stock has recovered from sharp dips in the past.
Still not sure about MDT stock? Consider the portfolio approach.
Portfolios Are The Smarter Way To Invest
Single stocks swing wildly, but staying invested matters. A well-built portfolio helps you stay invested, captures upside, and softens the blows from individual stocks.
Why settle for average market returns? The Trefis High Quality (HQ) Portfolio invests in a diverse group of 30 stocks that have collectively delivered stronger upside with reduced volatility compared to the broader indices. Discover the methodology behind these smoother, higher returns by checking the HQ Portfolio performance data.